Drugs / CHG/IPA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04756154 | Jul 2020 → Apr 2021 | — | Solventum US LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHG/IPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04756154 ↗ |
| Route | Topical | “Apply topically to the inguinal region for 2 minutes” NCT04756154 ↗ |